Of 14 metabolites identified, 2 appeared to have “robust” causal relationships with idiopathic pulmonary fibrosis.

BACKGROUND: Direct reprogramming of fibroblasts to cardiomyocytes is a potentially curative strategy for ischemic heart ...

Panelists discuss that improving outcomes for patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) requires multifaceted efforts including developing ...

Matrix rhythm therapy (MRT) is an innovative therapeutic approach that utilizes vibrational and rhythmic stimulation to ...

The UAB researchers showed that TREM2 — which stands for triggering receptors expressed on myeloid cells 2 — is predominantly ...

The study uncovers how ovarian ECM tropism influences endometriotic cell adhesion, paving the way for novel strategies to ...

Emerging ‘co-scientist’ systems use teams of chatbots to mimic the deliberations of a research group. Do they really help?

Elutia is a winner in the Innovation and Product Launches categories in the 2025 Medical Device Network Excellence Awards.

Scientists may have found a way to rewind the heart’s biological clock without even touching the cells. A team of researchers led by Assistant Professor Jennifer Young from the Department of ...

Scientists have found a novel way that includes a new lab-grown material that could help slow and even reverse some of the ...

Although fibrosis is an important function and helps repair heart tissue after damage, when it is uncontrolled, it leads to a stiffer, less flexible ECM. In the case of the heart, this can make it ...

With the improving survival of patients with cystic fibrosis (CF), the clinical spectrum of this complex multisystem disease continues to evolve. One of the most important clinical events for patients ...